FDA Inspection 1100374 — Gulf Coast Regional Blood Center At Westchase
The FDA completed an inspection of Gulf Coast Regional Blood Center At Westchase on Jun 14, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jun 14, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Houston, TX (United States)